Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT-Reference-Cited by-同舟云学术

Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT

Published:2024-08-14 Issue: Volume: Page:
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Mohty Razan^ORCID,Bazarbachi Abdul Hamid^ORCID,Labopin Myriam^ORCID,Esteve Jordi^ORCID,Kröger Nicolaus^ORCID,Cornelissen Jan J.,Blaise Didier^ORCID,Socié Gerard^ORCID,Maury Sébastien,Ganser Arnold,Gedde-Dahl Tobias,von dem Borne Peter^ORCID,Bourhis Jean Henri,Bulabois Claude Eric,Yakoub-Agha Ibrahim^ORCID,Pabst Caroline,Nguyen Stéphanie,Chevallier Patrice^ORCID,Huynh Anne,Bazarbachi Ali^ORCID,Nagler Arnon^ORCID,Ciceri Fabio^ORCID,Mohty Mohamad^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02384-2.pdf

Reference32 articles.

1. Bolon YTAR, Allbee-Johnson M, Estrada-Merly N, Lee SJ. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2022. Accessed from: https://cibmtr.org/CIBMTR/Resources/Summary-Slides-Reports. Accessed on July 30, 2024.

2. Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G, et al. De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer. 2021;127:2049–61.

3. El-Cheikh J, Bidaoui G, Saleh M, Moukalled N, Abou Dalle I, Bazarbachi A. Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Clin Hematol Int. 2023;5:143–54.

4. Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–1228.

5. Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.